2021
DOI: 10.1080/14786419.2021.1955361
|View full text |Cite
|
Sign up to set email alerts
|

A comprehensive insight on the biological potential of embelin and its derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 31 publications
(17 citation statements)
references
References 74 publications
0
15
0
Order By: Relevance
“…However, its cardiac side effects, leading to cardiomyopathy and congestive heart failure, have limited the clinical use of this potent anticancer drug. 56 Therefore, more effective therapeutic agents are needed considering previous reports of embelin against myocardial injury, 48 50 and since so far protective effects of embelin and embelin derivatives against anthracycline-induced cardiotoxicity have not been tested, 57 in the present study, we aimed to determine whether cardiotoxicity induced by chemotherapy could be attenuated by embelin derivatives when administrated in conjunction with chemotherapeutical agents.…”
Section: Results and Discussionmentioning
confidence: 99%
“…However, its cardiac side effects, leading to cardiomyopathy and congestive heart failure, have limited the clinical use of this potent anticancer drug. 56 Therefore, more effective therapeutic agents are needed considering previous reports of embelin against myocardial injury, 48 50 and since so far protective effects of embelin and embelin derivatives against anthracycline-induced cardiotoxicity have not been tested, 57 in the present study, we aimed to determine whether cardiotoxicity induced by chemotherapy could be attenuated by embelin derivatives when administrated in conjunction with chemotherapeutical agents.…”
Section: Results and Discussionmentioning
confidence: 99%
“…10 Fused pyrrole analogs as potential anticancer agents I compound (32) showed significant antiproliferative activity in MDA-MB human cancer cell lines. Many natural products are known to possess potential anticancer activity [114,115]. One such natural product, pyrrolomycin, a polyhalogenated antibiotic (33 a), has potent anticancer activity.…”
Section: Anticancer Agentsmentioning
confidence: 99%
“…This compound is reported to have antibacterial activity against Staphylococcus aureus, Streptococcus pyogenes, Shigella flexneri, Shigella sonnei, Pseudomonas aeruginosa, Shigella boydii, and Proteus mirabilis [20]. In addition, Embelin is also reported to exhibit anticancer, antioxidant, antimalarial, antiviral, antidiabetic, and anti-inflammatory activity [23]. Therefore, it could suggest that Embelin is the active antibacterial compound in JSR, even though other compounds are also prospective to be explored, such as 2,6-diamino-4hexenoic acid, palmitamide, and 3-hydroxybutyric acid.…”
Section: Embelinmentioning
confidence: 99%